Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
San Francisco Stem Cell Institute is a regenerative medicine clinic and biotechnology company based in San Francisco, California, operating as a division of Anatara Medicine. Founded by Dr. Ahvie Herskowitz, a former clinical professor at UCSF, the institute specializes in autologous stem cell therapies using stromal vascular fraction (SVF) derived from the patient's own adipose tissue. The company provides point-of-care cellular treatments for a variety of conditions, including orthopedic injuries, autoimmune disorders, and degenerative diseases. In addition to its clinical practice, the institute is an active member of the Cell Surgical Network, participating in multi-center clinical research to evaluate the safety and efficacy of regenerative medicine protocols. The institute focuses on an integrative approach, combining cellular therapies with personalized functional medicine to optimize patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on San Francisco Stem Cell Institute.